XML 35 R21.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Financial Instruments | 12 Months Ended
--- | ---
Dec. 31, 2024
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] |
Financial Instruments | 8. Financial Instruments The following table provides a summary of the Company’s significant financial assets carried at fair value and measured on a recurring basis (in thousands):
|  | Fair Value Measurements at December 31, 2024 |
|  | Carrying Value at December 31, 2024 |  |  | Quoted Prices in Active Markets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Restricted investments: |  |  |  |  |  |  |  |  |  |  |  |
Rabbi Trusts |  | $ | 59,495 |  |  | $ | 12,635 |  |  | $ | 46,860 |  |  | $ | — |
Marketable equity and fixed income securities |  |  | 54,392 |  |  |  | 2,069 |  |  |  | 52,323 |  |  |  | — |
Other non-current assets |  |  | 19,345 |  |  |  | — |  |  |  | 19,345 |  |  |  | — |
Interest rate swap derivatives |  |  | 4,851 |  |  |  | — |  |  |  | 4,851 |  |  |  | — |
|  | Fair Value Measurements at December 31, 2023 |
|  | Carrying Value at December 31, 2023 |  |  | Quoted Prices in Active Markets (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Restricted investments: |  |  |  |  |  |  |  |  |  |  |  |
Rabbi Trusts |  | $ | 51,247 |  |  | $ | 9,547 |  |  | $ | 41,700 |  |  | $ | — |
Marketable equity and fixed income securities |  |  | 47,382 |  |  |  | 19,010 |  |  |  | 28,372 |  |  |  | — |
Other non-current assets |  |  | 18,887 |  |  |  | — |  |  |  | 18,887 |  |  |  | — |
Interest rate swap derivatives |  |  | 3,849 |  |  |  | — |  |  |  | 3,849 |  |  |  | — |
The Company’s Level 2 financial instruments included in the tables above as of December 31, 2024 and December 31, 2023 consist of interest rate swap derivative assets/liabilities held by GEO, investments in equity and fixed income mutual funds held in the Company’s captive insurance subsidiary, Florina, the Company's rabbi trust established for employer contributions to The GEO Group, Inc. Non-qualified Deferred Compensation Plan and other non-current assets which include the cash surrender value of company-owned life insurance policies. The Company's Level 1 financial instruments included in the table above as of December 31, 2024 and 2023 consist of money market funds held in Florina and money market funds held in the Company's rabbi trust established for its Executive Chairman's retirement account. The interest rate swap derivative assets are valued using a discounted cash flow model based on projected borrowing rates. The Company's restricted investment in the rabbi trust for The GEO Group, Inc. Non-qualified Deferred Compensation Plan is invested in Company-owned life insurance policies which are recorded at their cash surrender values. These investments are valued based on the underlying investments held in the policies' separate accounts. The underlying assets are equity and fixed income pooled funds. The marketable equity and fixed income securities are valued using quoted rates. The company-owned life insurance policies included in other non-current assets are valued at their cash surrender values. As of December 31, 2023 and 2022 the Company held certain equity securities within its investments and approximately $1.0 million and $(1.0) million were including as an unrealized holding gain (loss) during the respective periods included within the statement of other comprehensive income. The unrealized holding gain was not significant during the year ended December 31, 2024.

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration